Word

MFUSION

Status

Dead

Status Code

602

Status Date

Friday, August 11, 2023

Serial Number

97486095

Mark Type

4000

Filing Date

Friday, July 1, 2022

Abandoned Date

Tuesday, July 25, 2023

Trademark Owner History

ModernaTx, Inc.

Classifications

5 Vaccines; vaccine adjuvants; medical, biological, and pharmaceutical preparations for medical use, namely, preparations containing messenger RNA for preventing and treating viruses, rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, and respiratory disorders; mRNA-based therapeutics and therapeutic agents for in vivo, ex vivo, or in situ prevention and treatment of viruses rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, and respiratory disorders; lipid nanoparticles for pharmaceutical, medical or diagnostic purposes; drug carriers for medical use, namely, lipid nanoparticles for delivering drugs; lipid nanoparticles for drug delivery sold as an integral component of drugs; pharmaceutical preparations, namely, messenger RNA and delivery agents comprised of lipid nanoparticle carriers and polymers for the delivery of mRNA to human cells

1 Medical, biological, and pharmaceutical preparations for scientific, research, medical laboratory use, or for the manufacture of pharmaceuticals, namely, preparations containing messenger RNA for preventing and treating viruses, respiratory disorders, rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, and metabolic disorders,; biochemicals for in vivo, ex vivo, or in vitro scientific research and medical research, namely, for use in the manufacture of pharmaceuticals for preventing and treating viruses, respiratory disorders, rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders,; lipid nanoparticles for scientific, laboratory or medical research use

42 Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines

M FUSION

Trademark Events

Aug 11, 2023

Abandonment Notice E-Mailed - Failure To Respond

Aug 11, 2023

Abandonment Notice Mailed - Failure To Respond

Aug 11, 2023

Abandonment - Failure To Respond Or Late Response

Aug 10, 2023

Teas Change Of Correspondence Received

Aug 10, 2023

Attorney/Dom.Rep.Revoked And/Or Appointed

Aug 10, 2023

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Aug 10, 2023

Applicant/Correspondence Changes (Non-Responsive) Entered

Aug 10, 2023

Teas Change Of Owner Address Received

Apr 24, 2023

Notification Of Non-Final Action E-Mailed

Apr 24, 2023

Non-Final Action E-Mailed

Apr 24, 2023

Non-Final Action Written

Apr 17, 2023

Assigned To Examiner

Jul 21, 2022

New Application Office Supplied Data Entered

Jul 5, 2022

New Application Entered